Massive Layoffs Expected at Boston ScientificMassive Layoffs Expected at Boston Scientific

Other factors: the debt from its $27 billion acquisition of Guidant, and a "corporate warning letter" from FDA that prevented the firm from introducing certain new products. One analyst expects the cuts to disproportionately affect the stent business. Boston Scientific eliminated about 500 jobs earlier this year and said more cuts were forthcoming. The firm has not confirmed when the cuts will be announced, but some analysts think it could come as early as this week. Third-quarter financial results will be announced Friday.It's always tough to hear about the rank-and-file losing their jobs because of blunders by management. Let's hope there are no bonuses this year for the folks whose poor decisions made this happen.UPDATE: The firm projects the number at 2300, and says cuts will commence this month and be completed by the end of the year.